About 220,000 patients expected to receive Mounjaro over three years as GPs can prescribe the drugs for the first time
Thousands of patients in England will be able to access weight-loss jabs via their GP from Monday for the first time.
The mass rollout on the NHS means family doctors will be allowed to prescribe the drugs for the first time. About 220,000 people with “greatest need” are expected to receive Mounjaro, also known as tirzepatide and made by Eli Lilly, on the NHS over the next three years.
The drug works by lowering blood sugar levels and slows down how quickly food is digested.
From Monday, GPs in England will be allowed to prescribe Mounjaro to severely obese people living with a range of other health problems. Patients previously needed to access the drugs through a special weight loss service.
